Summary of Investigations
Variable | At presentation | One month after initial presentation | Normal values |
---|---|---|---|
Haemoglobin (g/dL) | 12 | - | 13–17 (for male) |
TLC (/mm3) | 7,200 | - | 4,000–10,000 |
DLC | Polymorphs, 78% | - | Polymorphs, 40%–80% |
Lymphocytes, 18% | Lymphocytes, 20%–40% | ||
Monocyte, 2%–8% | |||
Eosinophils, 1%–6% | |||
Platelets (/mm3) | 340,000 | - | 150,000–450,000 |
Total bilirubin (mg/dL) | 2.2 | 11.6 | Up to 1.2 |
Conjugated bilirubin (mg/dL) | 1.4 | 9.6 | Up to 0.8 |
AST (U/L) | 60 | 86 | 10–40 |
ALT (U/L) | 16 | 30 | 10–40 |
SAP (U/L) | 308 | 336 | 40–130 |
GGT(U/L) | 126 | 69 | 10–50 |
Total protein (g/dL) | 7.0 | 8.2 | 6.2–7.9 |
Albumin (g/dL) | 2.6 | 4.4 | 3.2–5.3 |
INR | 1.31 | - | 1.0–1.3 |
HBsAg | NR | - | - |
Amoebic Serology | Positive | - | - |
USG upper abdomen | Abscess of 6.4 cm ×7.5 cm × 6.6 cm in the right lobe of the liver | Abscess of 5 cm × 6 cm × 5 cm in the right lobe of the liver | - |
IgM Anti HAV | - | Non-reactive | - |
IgM Anti HEV | - | Non-reactive | - |
Anti HCV | - | Non-reactive | - |
ANA/AMA/ASMA | - | Negative | - |
TLC, total leucocyte count; DLC, differential leucocyte count; AST, aspartate transaminase; ALT, alanine transaminase; SAP, serum alkaline phosphatase; GGT, gamma-glutamyltransferase; INR, international normalised ratio; HBsAg: Hepatitis surface Antigen; NR, non reactive; IgM, immunoglobulin M; Anti HAV, antibodies against hepatitis ‘A’ virus; Anti HEV, antibodies against hepatitis ‘E’ virus; Anti HCV: antibodies against hepatitis ‘C’ virus; ANA, anti-nuclear antibodies; AMA, anti-mitochondrial antibodies; ASMA, Anti-smooth muscle antibodies; -, not available.